###begin article-title 0
Switched alternative splicing of oncogene CoAA during embryonal carcinoma stem cell differentiation
###end article-title 0
###begin p 1
###xml 0 6 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
daggerZheqiong Yang is in the International Graduate Exchange Trainee Program between Medical College of Georgia and Wuhan University, China.
###end p 1
###begin p 2
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
###xml 828 831 828 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 925 928 925 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 976 979 976 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1105 1108 1105 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1061 1066 <span type="species:ncbi:9606">human</span>
###xml 1312 1317 <span type="species:ncbi:9606">human</span>
Alternative splicing produces functionally distinct proteins participating in cellular processes including differentiation and development. CoAA is a coactivator that regulates transcription-coupled splicing and its own pre-mRNA transcript is alternatively spliced. We show here that the CoAA gene is embryonically expressed and alternatively spliced in multiple tissues to three splice variants, CoAA, CoAM and CoAR. During retinoic-acid-induced P19 stem cell differentiation, the expression of CoAA undergoes a rapid switch to its dominant negative splice variant CoAM in the cavity of the embryoid body. CoAM functionally inhibits CoAA, and their switched expression up-regulates differentiation marker Sox6. Using a CoAA minigene cassette, we find that the switched alternative splicing of CoAA and CoAM is regulated by the cis-regulating sequence upstream of the CoAA basal promoter. Consistent to this, we show that p54nrb and PSF induce CoAM splice variant through the cis-regulating sequence. We have previously shown that the CoAA gene is amplified in human cancers with a recurrent loss of this cis-regulating sequence. These results together suggest that the upstream regulatory sequence contributes to alternative splicing of the CoAA gene during stem cell differentiation, and its selective loss in human cancers potentially deregulates CoAA alternative splicing and alters stem cell differentiation.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 332 333 332 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 334 335 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 412 415 412 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5 B6 B7">5&#8211;7</xref>
###xml 638 639 638 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 723 724 723 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 184 189 <span type="species:ncbi:9606">human</span>
###xml 316 321 <span type="species:ncbi:9606">human</span>
Most eukaryotic genes contain interspersed introns that are removed from pre-mRNA by RNA splicing to yield functional mRNA (1,2). In addition to constitutive splicing, the majority of human gene transcripts is alternatively spliced, producing distinct mRNA products which contribute greatly to the complexity of the human proteome (3,4). Alternative splicing is cell-type-specific and developmentally regulated (5-7). Splicing variants yield functionally different proteins which are often critical for specific cellular functions. In contrast, altered alternative splicing patterns are often associated with different types of diseases (8), and aberrant alternative splicing is one of the characteristics of cancer cells (9).
###end p 5
###begin p 6
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1022 1024 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1025 1027 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
Alternative splicing has been extensively shown to be coupled with transcriptional regulation. A number of regulatory proteins may be involved in alternative splicing decisions. These proteins are in the spliceosome particles, the SR protein family (10), the heterogeneous nuclear ribonucleoproteins (hnRNPs) and a number of cofactor proteins involved in transcriptional regulation (11). Although intronic and exonic sequence elements within pre-mRNA are required for splicing, substantial evidence also suggests that protein complexes recruited by promoter sequences determine, in a transcription-coupled manner, the choices and patterns of alternative splicing (12,13). For example, steroid hormones have been shown to regulate alternative splicing through nuclear hormone receptors and their coactivators in promoter complexes (12). One mechanism by which promoter sequences may influence splicing is by directing the assembly of splicing factors on the RNA polymerase II (RNAP) C-terminal domain during RNA synthesis (14,15).
###end p 6
###begin p 7
###xml 18 21 18 21 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">coa</underline>
###xml 30 31 30 31 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</underline>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 489 492 489 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 956 958 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1097 1100 1097 1100 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">coa</underline>
###xml 1109 1110 1109 1110 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</underline>
###xml 1194 1196 1194 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1325 1327 1325 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1328 1330 1328 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1002 1007 <span type="species:ncbi:9606">human</span>
Coactivator CoAA (coactivator activator) was originally cloned as a nuclear receptor coactivator TRBP/NcoA6-interacting protein (16,17). CoAA stimulates transcriptional activation mediated by nuclear receptors and transcription factors, and also regulates alternative splicing through a number of steroid hormone receptor-stimulated promoters (12,18). CoAA (also known as paraspeckle protein 2, PSP2) is a major component of nuclear paraspeckles and is colocalized with splicing factor p54nrb (19,20). CoAA is a member of the hnRNP family and contains two N-terminal RNA recognition motifs (RRMs) and a C-terminal transcriptional activation domain with 27 repeating tyrosine- and glutamine-rich motifs (16,21). Both RRMs and the C-terminal activation domain are essential for CoAA activities. The C-terminal repeats are homologous to sequences in a family of oncoproteins containing EWS (Ewing's sarcoma) and TLS/FUS (translocation/fusion in liposarcoma) (21), which regulate alternative splicing. The human CoAA gene itself is also alternatively spliced. One of the splice variants, termed CoAM (coactivator modulator), contains the N-terminal RRMs but lacks the C-terminal activation domain (16). CoAM serves as a natural dominant negative form antagonizing the functions of CoAA in transcription and alternative splicing (16,18).
###end p 7
###begin p 8
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 78 83 <span type="species:ncbi:9606">human</span>
We have recently shown that the CoAA gene at chromosome 11q13 is amplified in human cancers including lung and skin cancers (21). Molecular analysis reveals the CoAA-coding sequence and its basal promoter are retained within the amplicon, whereas a upstream sequence is not (21). The recurring gene aberration with loss of the CoAA regulatory sequence implies a potential functional importance of the CoAA gene regulation, including its alternative splicing. In this study, using an embryonal carcinoma (EC) P19 stem cell neuronal differentiation system, we demonstrate that the expression of CoAA dramatically switches to its alternative splicing variant CoAM in cells destined to form the cavity of embryoid bodies (EBs). Overexpression of CoAM induces differentiation marker Sox6 in the absence of retinoic acid (RA), suggesting the switch from CoAA to CoAM expression may play an important role in promoting differentiation. Furthermore, we show that deletion of a CoAA upstream regulatory element, which is lost in a number of cancers, impairs the switch in alternative splicing from CoAA to CoAM in a CoAA minigene cassette. In particular, CoAA down-regulation is absent. Data thus support a model in which loss of the regulatory element disturbs the balance of alternative splicing of the CoAA gene and results in constant CoAA expression and defective CoAM expression. This defect may promote maintenance of a stem cell phenotype and prevent differentiation. In summary, our study indicates that switched alternative splicing of the CoAA gene is regulated by its upstream sequence during stem cell differentiation.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Immunohistochemistry
###end title 10
###begin p 11
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 801 802 801 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 132 139 <span type="species:ncbi:9986">rabbits</span>
###xml 399 404 <span type="species:ncbi:10090">mouse</span>
###xml 771 777 <span type="species:ncbi:9986">rabbit</span>
###xml 786 791 <span type="species:ncbi:10090">mouse</span>
Polyclonal anti-CoAA antibody (CoAA specific, against 307-545 aa) and anti-RRM antibody (against 1-156 aa of CoAM) were prepared in rabbits by immunization with GST fusion proteins (Covance). His-tagged CoAA protein as antigen was crosslinked to the Affi-gel 10 resin according to the manufacturer's protocol (Bio-Rad), and was used for affinity purification of anti-CoAA (21). Sagittal sections of mouse embryonic tissue at E12.5 and E15.5 were stained with affinity purified anti-CoAA at a dilution of 1:250. The P19 EBs were paraffin-embedded and the sections were stained with anti-CoAA, anti-RRM antibodies at dilution of 1:500 and with anti-active caspase-3 peptide antibody at 1:200 (USBiological, C2087-16A). Antibody binding was detected using biotinylated anti-rabbit or anti-mouse IgG F(ab)2 secondary antibody followed by detecting reagents (DAKO). Sections were counterstained with hematoxylin.
###end p 11
###begin title 12
Immunoblotting
###end title 12
###begin p 13
###xml 237 240 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Endogenous CoAA and CoAM in P19 cells were detected using whole-cell extracts at each differentiating stage and probed with anti-RRM antibody. For antibody evaluation, CoAA and CoAM were overexpressed in CV1 cells under the control of a CMV promoter in pcDNA3 vector (Invitrogen). Immunoblots were probed with anti-CoAA and anti-RRM primary antibodies at a dilution of 1:200 and detected with the ECL system (Amersham Pharmacia).
###end p 13
###begin title 14
P19 cell and ES cell culture and differentiation
###end title 14
###begin p 15
###xml 233 234 221 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 314 319 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 614 616 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1005 1007 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 101 107 <span type="species:ncbi:9913">bovine</span>
###xml 108 112 <span type="species:ncbi:9913">calf</span>
###xml 134 140 <span type="species:ncbi:9913">bovine</span>
###xml 267 273 <span type="species:ncbi:10090">murine</span>
###xml 778 783 <span type="species:ncbi:10090">Mouse</span>
###xml 890 895 <span type="species:ncbi:10090">mouse</span>
Mouse EC P19 cells were maintained in alpha-modified minimum essential medium supplemented with 7.5% bovine calf serum and 2.5% fetal bovine serum, 100 U/ml penicillin and 0.1 microg/microl streptomycin. Cells were incubated in 5% CO2 at 37degreesC. Undifferentiated murine EC P19 cells were induced by 500 nM all-trans RA (Sigma) up to 4 days in suspension culture to form EBs (EB2-EB4). The EBs were trypsinized and plated in tissue culture dish. The cells were further differentiated (D3-D12) for an additional 12 days in the absence of RA. P19 cells were transfected with the plasmid or siRNA of CoAA (25 nM) (21), when applicable, using Lipofectamine 2000 reagent (Invitrogen) for 24 h before harvest. Total amounts of DNA for each well were balanced by adding vector DNA. Mouse embryonic stem (ES) cells (D3, 129S2/SvPas blastocysts, ATCC) were maintained on gamma-irradiated (30 Gy) mouse embryonic fibroblast feeder layers. The culture and differentiating conditions were as previously described (22). Briefly, neuronal differentiation of ES-cell-derived EBs was induced by 1000 nM RA for 6 days to form EBs (EB2-EB6). Undisrupted EBs were differentiated in culture in the absence of RA for an additional 15 days (D3-D15) before harvest.
###end p 15
###begin title 16
Luciferase assay
###end title 16
###begin p 17
###xml 188 189 186 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 94 100 <span type="species:ncbi:9913">bovine</span>
###xml 377 381 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
CV-1 cells were maintained in Dulbecco's modified Eagle's medium, supplemented with 10% fetal bovine serum and 100 U/ml penicillin and 0.1 mug/mul streptomycin, and were incubated in 5% CO2 at 37degreesC. CV-1 or P19 cells were transfected in triplicate in 24-well plates using Lipofectamine 2000 (Invitrogen). Cells were incubated with ligand dexamethasone (100 nM) to induce MMTV-luciferase reporter, when applicable, for 16 h before harvest. Total amounts of DNA for each well were balanced by adding vector DNA. Relative luciferase activities were measured by a Dynex luminometer. Data are shown as means of triplicate transfections +/- standard errors.
###end p 17
###begin title 18
Construction of CoAA minigene
###end title 18
###begin p 19
###xml 87 95 87 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 395 403 383 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 293 298 <span type="species:ncbi:9606">human</span>
###xml 1174 1177 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
To facilitate promoter analysis, a shortened CoAA minigene was constructed as shown in Figure 5A. The CoAA minigene was designed to prevent the expression of functional CoAA and CoAM proteins that otherwise might interfere with splicing of its own minigene. Excluding the promoter region, the human CoAA gene spans approximately11 kb containing three exons, nt 1-432, 7589-9053 and 9836-10 718 (Figure 5A). Deletions were introduced to the minigene within the first intron (645-7419), within the second exon (7876-8801) that encodes the activation domain, and within the third exon (10 044-10 718) containing the 3' untranslated region. A 1-nt (G) insertion in the first exon disrupted the open reading frame and prevented the production of RRM domains. Expression of CoAA and CoAM transcripts was detected using vector-specific primers that distinguish the minigene and the endogenous gene transcripts. A cassette consisting of the CoAA minigene linked naturally to various fragments of its own promoter was inserted into a promoter-less pcDNA3 vector (BglII to XhoI). As a control, a separate construct was prepared with the CoAA minigene expressed under the control of a CMV promoter in pcDNA3.
###end p 19
###begin title 20
RT-PCR and real-time quantitative PCR
###end title 20
###begin p 21
###xml 518 521 509 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 51 56 <span type="species:ncbi:9606">human</span>
Normalized first-strand cDNAs from multiple normal human tissues and cancer cell lines (MTCtrade mark panels, Clontech) were analyzed by PCR using primer pairs common to all CoAA splicing forms. For P19 cells, total RNA was isolated at each differentiation stage using Trizol reagent (Invitrogen), treated with DNase I, and normalized for their concentrations before use. RT-PCR was performed using the one-step RT-PCR kit (Qiagen). In transfection experiments, P19 cells were cotransfected with CoAA minigenes and p54nrb or PSF expression plasmids. Primer pairs used in RT-PCR are as follows: (from 5' to 3') primers common to endogenous CoAA, CoAM and CoAR splicing forms, atgaagatattcgtgggcaa, ctaaacgccggtcggaacc; CoAM-specific, tctccaccaagggtatggtt, ctacatgcggcgctggta; Nanog, agggtctgctactgagatgctctg, caaccactggtttttctgccaccg; Oct4, ctgagggccaggcaggagcacgag, ctgtagggagggcttcgggcactt; Sox6, cagcggatggagaggaagcaatg, ctttttctgttcatcatgggctgc; MAP2, ggacatcagcctcactcacaga, gcagcatgttcaaagtcttcacc; GFAP, gaatgactcctccactccctgc, cgctgtgaggtctggcttggc; and GAPDH, accacagtccatgccatcac, tccaccaccctgttgctgta. Primer pairs for detecting transcripts from the CoAA minigene are as follows: F, aatgtgtcggctgcatgc; B, ctaaacgccggtcggaacc; C, tatgaagagatacgccctggttcc; V, atggctggcaactagaaggcac; J, tctccaccaagggtatggtt; and A, gcctggctggccgcggtag. Real-time quantitative RT-PCR primers: CoAA, cttcgactaccagcaggctttt, ccgtcagaggcgccacataag; and CoAM, caaagaagtgaagggcaagc, aatccagcgaggactttgtc. Quantitative RT-PCR was performed on iCycler (BioRad) using SYBR Green I (Invitrogen).
###end p 21
###begin title 22
Chromatin immunoprecipitation (ChIP)
###end title 22
###begin p 23
###xml 524 527 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 722 723 716 717 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
P19 cells at each stage of differentiation were treated with 1% formaldehyde for 10 min, and the crosslinking was stopped by 125 mM glycine. Cells were lysed and sonicated in the buffer containing 20 mM Tris pH 8.0, 75 mM NaCl, 75 mM KCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 10% glycerol, 1 mM DTT and protease inhibitors. Immunoprecipitation was carried out using salmon sperm DNA-blocked protein A/G resin (Upstate), and anti-RNAP II (8WG16, Covance), or anti-SRp20 (Santa Cruz), or anti-NF-YA (Santa Cruz), or anti-p54nrb (BD biosciences) in the above buffer except with 0.1% Triton at 4degreesC overnight. The resin in the absence of antibody was a control. The crosslinking was reversed by eluting with 0.1 M NaHCO3, 1% SDS, 0.3 M NaCl at 65degreesC for 4 h. Purified DNA (Qiagen kit) was subjected to PCR analysis. Input was 1% extract before immunoprecipitation. Primer pairs used are the following: -80 bp, ggccggaggtagctcttctgac, ctccacaggaatggctggcgac; -3000 bp, attagaaatgcctttcaagggg, cttcggctgatagtggacatac; and -8500 bp, caggcggactcggttctttgag, caaacctcatatacggagtcgc.
###end p 23
###begin title 24
Sequence analyses and CoAR accession
###end title 24
###begin p 25
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 387 392 <span type="species:ncbi:9606">Human</span>
Alu repeats within the regulatory sequences of the CoAA gene were identified using Censor Server at Genetic Information Research Institute () and the BLAST search at the National Center for Biotechnology Information (NCBI). Transcription-factor-binding sites within the CoAA basal promoter were predicted by the TFSEARCH program at the Computational Biology Research Center of Japan (). Human CoAR sequences reported in this article have been deposited at GenBank/EBI Data Bank with accession number DQ294957.
###end p 25
###begin title 26
RESULTS
###end title 26
###begin title 27
Alternative splicing of CoAA gene transcripts
###end title 27
###begin p 28
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBM14</italic>
###xml 285 293 273 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 297 299 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 300 302 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 466 468 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 470 472 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 656 658 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 659 661 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 772 775 760 763 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">coa</underline>
###xml 784 785 772 773 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</underline>
###xml 869 877 857 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1242 1250 1230 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1340 1348 1328 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 808 813 <span type="species:ncbi:9606">human</span>
The human CoAA gene (gene symbol RBM14) contains three exons spanning approximately11 kb. We have previously shown that the CoAA gene is alternatively spliced and produces CoAA and CoAM transcripts through competitive 5' alternative splicing events between the second and third exons (Figure 1A) (16,21). The resulting CoAA and CoAM proteins share two N-terminal RRM domains, but only CoAA possesses the C-terminal activation domain containing repeated YxxQ motifs (16, 21). Consequently, CoAA is a potent transcriptional coactivator, whereas CoAM competes with CoAA via shared RRM domains and represses CoAA activities in both transcription and splicing (16,18). In this study, using RT-PCR analysis we identified a third splice variant of CoAA, designated here as CoAR (coactivator regulator), in multiple human adult and embryonic tissues, and in cancer cell lines (Figure 1B). Sequencing analysis indicated that the CoAR transcript was derived by joining the first and third exons, skipping the entire second exon and altering the reading frame for the third exon. CoAR contains only one RRM domain encoded by the first exon. The transcriptional activity of CoAR is moderately repressive when expressed in a transient transfection assay (Figure 1C). This splice variant was previously undetected due to its low abundance in HeLa cells (Figure 1B), in which CoAA and CoAM were originally cloned. The nucleotide and amino-acid sequences of CoAR have been deposited at the NCBI with accession number DQ294957. 
###end p 28
###begin p 29
###xml 92 100 92 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 357 365 357 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 457 462 <span type="species:ncbi:9606">human</span>
The CoAA mRNA transcript is expressed in all tissues and cells examined as shown by RT-PCR (Figure 1B), a result consistent with previous northern blot analysis (16). Sequence analyses confirmed that the three PCR products observed are the three CoAA splice variants. The CoAA transcript is relatively abundant in both normal tissues and cancer cell lines (Figure 1B). However, the relative levels of CoAA, CoAM and CoAR mRNAs vary between samples. In some human fetal tissues and cancer cell lines, CoAM or CoAR expression is below the limits of detection. The variation in the expression ratios of CoAA isoforms, which could partially due to the alternative splicing regulations, represents a possible cell-specific control of CoAA activity through its inhibitory splice variants.
###end p 29
###begin title 30
Switched alternative splicing of CoAA and CoAM during P19 stem cell differentiation
###end title 30
###begin p 31
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 83 89 <span type="species:ncbi:10090">murine</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
To investigate CoAA alternative splicing in a physiological context, we analyzed a murine EC stem cell line, P19, during neuronal differentiation. P19 is a teratocarcinoma-derived pluripotent stem cell line that can give rise to all three germ layers in mice (23). Undifferentiated P19 EC cells in culture can be induced by RA to differentiate to neuronal and glial cells (24,25) or by DMSO to cardiac and skeletal muscles (26). Treatment of P19 EC cells with RA for up to 4 days induces non-adhering aggregates called EBs which resemble the inner cell mass of embryos (27,28). Prolonged culture in the absence of RA for an additional 12 days induces neuronal differentiation into a mixture of cell types including differentiated neurons and glial cells, as well as a variety of partially differentiated or undifferentiated cells (23).
###end p 31
###begin p 32
###xml 282 290 282 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 655 663 655 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 807 815 807 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 878 886 878 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 993 995 993 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1015 1017 1015 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1018 1020 1018 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1068 1076 1068 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1143 1144 1143 1144 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</underline>
###xml 1148 1150 1148 1150 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ox</underline>
###xml 1165 1170 1165 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32 B33 B34">32&#8211;34</xref>
###xml 1605 1613 1605 1613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1502 1507 <span type="species:ncbi:10090">mouse</span>
We analyzed the expression of endogenous CoAA and its splicing variant transcripts using RNA isolated at different time points during P19 cell differentiation. Expression of CoAA shows a rapid but transient decrease, reaching the minimum at Day 4 corresponding to the EB formation (Figure 2A). In contrast, the expression of CoAM is drastically increased during EB formation, reaching the maximum level at Day 4 and declining rapidly during further differentiation. These data indicate that an alternative splicing switch between CoAA and CoAM occurs during EB formation. The expression of CoAR is very low and without significant change at the EB stage (Figure 2A). We focused our subsequent analysis on CoAA and CoAM. The switched expression was confirmed using primer pairs common to both CoAA and CoAM (Figure 2B), and was quantitatively measured by real-time PCR analysis (Figure 2C). A number of differentiation markers were analyzed simultaneously as controls. The expression of Nanog (29) followed by Oct4 (30,31), and then by CoAA declines upon RA treatment (Figure 2A). Meanwhile, the expression levels of Sox6, a member of the Sox (SRY box) gene family (32-34), microtubule-associated protein-2 (MAP2), a neuronal marker, and glial fibrillary acidic protein (GFAP), a glial cell marker, increase sequentially during neuronal differentiation. These data together suggest that a switched expression of CoAA transcripts occurs during the EB stages of P19 cell differentiation. We also examined mouse ES cells and switch from CoAA to CoAM expression was also found in ES cells during EB formation (Figure 2D). Since the EB of ES cells was undisrupted in continued culture condition, the down-regulation of CoAM was delayed, correlating to the presence of EB. In addition to RA-induced neuronal differentiation, the switched expression of CoAA and CoAM was also detected during DMSO-induced muscle differentiation of P19 cells (not shown). These results indicate that the increase of CoAM, which inhibits CoAA transcriptional activity, might be common in different type of stem cell differentiation at the EB stage. 
###end p 32
###begin p 33
###xml 478 486 478 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 596 604 596 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
To detect the expression of CoAA and CoAM at the protein level, we evaluated the two CoAA polyclonal antibodies. One was raised against the two N-terminal RRM domains (anti-RRM) for detecting both CoAA and CoAM, and the other was raised against the CoAA-specific C-terminal activation domain (anti-CoAA). A CoAM-specific antibody is not feasible due to its overlapping primary sequence with CoAA. The two antibodies detected both endogenous and overexpressed CoAA in 293 cells (Figure 3A). The endogenous CoAM protein level is very low in this cell line, which is consistent with its mRNA level (Figure 1B). 
###end p 33
###begin p 34
###xml 240 248 240 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 436 444 436 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 600 608 600 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 782 790 782 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 904 912 904 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1226 1228 1226 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 1446 1454 1446 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1532 1541 1532 1541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figures 2</xref>
###xml 1547 1548 1547 1548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 1898 1900 1898 1900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
Since CoAM mRNA is significantly elevated in EBs of P19 cells, we compared the staining pattern of the two antibodies to infer the expression pattern of CoAM. EBs are large multi-cell aggregates that form cavities at Day 4 of RA induction (Figure 3B) (25,27). CoAA expression, assessed by anti-CoAA, was detected in almost all cells of early-stage EBs, but only in the outer layer of mature EBs. CoAA was not detected in the EB cavity (Figure 3C). In contrast, the high level of expression of CoAM, detected by anti-RRM with the comparison of anti-CoAA, was found predominantly within the EB cavity (Figure 3C). The majority of signals within the cavity is unlikely contributed by CoAR when the mRNA level is considered, especially, when further confirmed by western blot analysis (Figure 3D). Most of the CoAM protein appears to be in cytoplasm although a low level of nuclear CoAM may also be present (Figure 3C). This pattern was also confirmed by overexpression of a Flag-tagged CoAM in P19 cells (Supplementary Figure S3). A mechanism in regulating the nuclear-cytoplasm shuttle of CoAM at this stage is unclear, however, other splicing regulators have been reported to be shuttled between the nucleus and the cytoplasm (35). The rapid decline of CoAM expression in later stages of differentiation might be due to the loss of CoAM-containing cells through apoptosis in the cavity, where a high level of cleaved active caspase-3 was present (Figure 3C). CoAM mRNA levels appear to decline more rapidly than CoAM protein levels (Figures 2A and 3D). At the D3 stage, CoAM protein still remains but CoAM mRNA is almost absent. This is possibly due to the longer protein half-life and the shorter mRNA half-life during degradation processes when cells become apoptotic. Our data together suggest that cells expressing CoAM are located in the EB cavity. Since CoAM potently represses transcription (16), it may regulate target gene expression and splicing during essential steps of cavitation at the EB stage.
###end p 34
###begin p 35
###xml 441 449 441 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 838 846 838 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 127 132 <span type="species:ncbi:10090">mouse</span>
To confirm the involvement of CoAA in neuronal differentiation, we compared the endogenous CoAA protein expression patterns in mouse embryonic tissues at gestational stages of E12.5 and E15.5 by immunohistochemistry. In the developing brain, CoAA is widely expressed in the neocortex at E12.5. The expression is reduced in the ventricular zone at E15.5, but is enriched in neurons migrated to the cortical plate that raises cerebral cortex (Figure 3E). Due to the high expression level of CoAA and low expression levels of CoAM and CoAR, the anti-RRM antibody that detects all three CoAA splicing forms was unable to distinguish from anti-CoAA in immunohistochemical staining (data not shown). However, the data did not exclude the possibility that CoAM and CoAR are present in certain tissues, in which their mRNAs were detected by PCR (Figure 1B). In addition, high levels of CoAA expression were detected in almost all fetal tissues at E12.5 (Supplementary Figure S1). By contrast, at E15.5, CoAA expression appeared to be restricted to certain cell types during differentiation (Supplementary Figure S2). These results nonetheless suggest that the CoAA is a predominant form and is expressed in a cell-specific manner during differentiation in multiple tissues including brain.
###end p 35
###begin title 36
Decreased CoAA and increased CoAM induce Sox6 expression in P19 cells
###end title 36
###begin p 37
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 857 865 857 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1121 1123 1121 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1385 1393 1385 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1870 1878 1870 1878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
The ability of CoAM to antagonize CoAA function, together with the dramatic decrease of CoAA and the increase of CoAM in the EB cavity, raise the possibility that the switch of CoAA and CoAM might be involved in regulating differentiation. To test this hypothesis, we altered CoAA and CoAM levels by overexpressing or RNAi, and monitored the expression level of differentiation marker genes, including Sox6 and MAP2. Sox6 is a member of a protein family defined by a high mobility group protein domain, called SRY box. Sox family proteins are widely involved in differentiation including sex determination, and in brain, bone and muscle development (36). Sox6 is known to be up-regulated during neuronal differentiation in P19 cells (32) and has a function in pre-mRNA splicing (37). Since the up-regulation of CoAM is immediately followed by that of Sox6 (Figure 2A), we chose Sox6 as one of the marker genes for analysis. We overexpressed CoAM or applied CoAA RNAi in undifferentiated P19 cells in the absence of RA. The siRNA for CoAA was evaluated in P19 cells (Supplementary Figure S4) and was previously described (21). While earlier differentiation markers such as Nanog or Oct4 did not change levels in the absence of RA induction, the expression of Sox6 and the neuronal marker MAP2 was induced by overexpressing CoAM or by the treatment with CoAA siRNA in the absence of RA (Figure 4). The endogenous CoAA level was decreased during both treatments. The data indicate that CoAA and CoAM may be specific in regulating a subset of genes including Sox6, especially in their downstream differentiation pathways. However, the increased Sox6 level was transient in contrast to the effect of RA induced differentiation, which produced a sustained elevation of Sox6. The relapse effect might be due to the transient increase of CoAM or the transient decrease of CoAA (Figure 4). These data nevertheless suggest that CoAA and CoAM are able to directly or indirectly regulate Sox6. It is still yet to be known whether CoAA and CoAM are necessary or sufficient to maintain the differentiation program in the absence of RA induction. In summary, the ratio of CoAA and its dominant negative CoAM may be critical during P19 stem cell differentiation, particularly at the EB stage. 
###end p 37
###begin title 38
Construction of CoAA minigene
###end title 38
###begin p 39
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 356 359 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 745 748 745 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 407 412 <span type="species:ncbi:9606">human</span>
Alternative splicing is regulated at multiple levels, particularly when coupled with transcriptional activation (11,14). Evidence has suggested that alternative splicing can be regulated through intronic or exonic enhancers and silencers as well as differential usage of promoter and regulatory sequences (10,13). We have previously identified the loss of cis-regulatory sequences of amplified CoAA gene in human cancers (21), suggesting that this sequence may play an important regulatory role. To investigate if this sequence regulates the alternative splicing of the CoAA gene in P19 cells, we constructed a shortened CoAA minigene with intact splicing junctions. The minigene is under the control of CoAA promoter with or without its native cis-regulating sequences. Thus, the CoAA minigene splicing can be analyzed in P19 cells using transient transfection approach.
###end p 39
###begin p 40
###xml 447 455 447 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 700 708 700 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 890 898 890 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1088 1096 1088 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1269 1277 1269 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 613 616 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 988 992 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
The design of the minigene ensures that no functional CoAA or CoAM protein is expressed but alternative splicing capability is preserved. The rationale for this design is to eliminate the potential effect of the CoAA protein in regulating its own splicing. The CoAA minigene was constructed with a shortened first large intron, a reading frame-shift mutation in the first exon and a deletion within the second exon encoding the activation domain (Figure 5A) (see Materials and methods section). A minimum of 160 nucleotides surrounding each splicing site was left intact. The minigene was first evaluated under a CMV promoter by RT-PCR using vector-specific primers to avoid endogenous interference (Figure 5A and B). The results demonstrate that the CoAA minigene was capable of producing both CoAA and CoAM equivalent transcripts, when CoAA and CoAM cDNAs were used as positive controls (Figure 5B). We also verified that the CoAA minigene has no coactivator effect on activation of an MMTV-luciferase reporter, which is consistent with the predicted absence of CoAA or CoAM functions (Figure 5C). Although potential intronic or exonic regulatory elements in the minigene could be affected, our data indicate that the CoAA minigene preserves its splicing capability (Figure 5B), as well as its switching capacity (see below). 
###end p 40
###begin p 41
###xml 112 115 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 341 349 341 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 567 570 567 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 649 657 649 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 878 886 878 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 896 898 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 926 929 926 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 1045 1048 1045 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1092 1100 1092 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1311 1314 1311 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 1326 1329 1326 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1444 1447 1444 1447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 216 221 <span type="species:ncbi:9606">human</span>
###xml 467 472 <span type="species:ncbi:9606">human</span>
###xml 474 479 <span type="species:ncbi:10090">mouse</span>
###xml 484 487 <span type="species:ncbi:10116">rat</span>
###xml 537 542 <span type="species:ncbi:9606">human</span>
###xml 711 716 <span type="species:ncbi:10090">mouse</span>
###xml 766 771 <span type="species:ncbi:9606">human</span>
The minigene was then constructed under control of the CoAA basal promoter with various lengths of its upstream cis-regulatory sequence to evaluate the regulation of the alternative splicing switch in P19 cells. The human CoAA gene contains a highly GC-rich basal promoter with predicted transcription-factor-binding sites for Sp1 and NF-Y (Figure 5D and Supplementary Figure S5). These transcription-factor-binding sites and their spacing are highly conserved among human, mouse and rat species. Within a 10 kb sequence upstream of the human CoAA gene, there are 21 Alu repeats, which belong to the short interspersed repetitive sequences (SINEs) (Figure 5D). A similar pattern of SINEs is also present in the mouse CoAA gene. We have previously cloned 5 kb of the human CoAA upstream sequence and generated a series of deletion fragment constructs with a luciferase reporter (Figure 5D and E) (21). Serial deletions of this Alu-rich sequence significantly increased the reporter expression in P19 cells, suggesting that this region contains a cis-acting silencing element in transcription (Figure 5E). Further deletion of the basal promoter region successively reduced the transcription activity, indicating that an intact basal promoter is essential for gene activation. Together, these data suggest that an Alu-containing cis-regulating element and the CoAA basal promoter are functionally required in P19 cells. The various lengths of the cis-regulating sequences in the CoAA minigene were then compared in subsequent splicing analysis.
###end p 41
###begin title 42
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
p54nrb and PSF are involved in regulating of the alternative splicing of CoAM
###end title 42
###begin p 43
###xml 235 238 235 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 252 255 252 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 399 404 399 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38 B39 B40 B41 B42 B43">38&#8211;43</xref>
###xml 434 437 434 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 560 563 560 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 671 679 671 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 732 735 732 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 813 816 813 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 828 831 828 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 868 876 868 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1064 1067 1064 1067 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 1210 1213 1210 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1415 1418 1415 1418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 1442 1445 1442 1445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 1636 1639 1636 1639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 1744 1747 1744 1747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 1954 1957 1954 1957 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 2129 2132 2129 2132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 2244 2247 2244 2247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1155 1158 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1326 1329 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
We first tested the alternative splicing of the CoAA minigene in P19 cells using two well-characterized splicing regulators, polypyrimidine tract binding protein-associated splicing factor (PSF) and p54 nuclear RNA-binding protein (p54nrb). PSF and p54nrb are RRM-containing proteins that have been suggested to regulate pre-mRNA splicing and to associate with transcription and splicing complexes (38-43). Both endogenous PSF and p54nrb are present in undifferentiated P19 cells (not shown). In the absence of RA induction, overexpression of either PSF or p54nrb in undifferentiated P19 EC cells induced a very significant elevation of endogenous CoAM, but not of CoAA (Figure 6A). The stimulation of CoAM expression by PSF and p54nrb was also evident in cells transfected with the P0 minigene, that carries the cis-regulating Alu-containing sequence (-5000 to +88) (Figure 6A). However, there was much less induction of CoAM transcript when the CoAA P2 minigene was driven only by the CoAA basal promoter (-1320 to +88) under the same condition. In addition, p54nrb, but not PSF, significantly induced CoAM expression from the CoAA minigene driven by a CMV promoter. These data suggest that inclusion of the cis-regulating sequence in the minigene promotes CoAM splicing similar to that in the endogenous gene. In contrast, CMV has a different promoter protein complex assembly, which may permit regulation by p54nrb but not by PSF. The p54nrb mRNA is relatively constant while PSF mRNA increased in RA-induced P19 cells as detected by RT-PCR analysis (not shown). There is no apparent correlation between the expression levels of p54nrb and PSF and the switch from CoAA to CoAM during RA-induced differentiation. Thus, the involvement of p54nrb and PSF in regulating alternative splicing of the CoAA gene might be due to their protein modifications at the particular differentiation stage. RA may induce certain signaling pathways that lead to the p54nrb/PSF activation in a splicing complex responsible for CoAM expression. Our data minimally suggest that the alternative splicing of CoAM can be regulated through PSF and p54nrb, although other splicing factors might also be involved. The data also indicate that the promoter and upstream cis-regulating sequences are involved in alternative splicing decisions. 
###end p 43
###begin p 44
###xml 201 204 201 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 457 460 457 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 537 540 537 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 552 555 552 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 578 587 578 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figures 6</xref>
###xml 615 618 615 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 788 791 788 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 937 940 937 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 1102 1110 1102 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1436 1439 1436 1439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 1521 1524 1521 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
To seek potential mechanism for the involvement of CoAA promoter and regulatory sequence in alternative splicing, we performed chromatin immunoprecipitation (ChIP) analysis using antibodies against p54nrb, RNAP II, one of the SR proteins named SRp20, and transcription factor NF-Y, whose binding sites are present in the CoAA promoter (Supplementary Figure S5). ChIP analysis suggests that there are physical interactions of protein complexes containing p54nrb, RNAP II, SRp20 and NF-Y with the CoAA basal promoter region as well as the Alu-containing cis-regulating sequences (Figures 6B and C). NF-Y, RNAP II, p54nrb and SRp20 all strongly interact with the CoAA basal promoter region (-80 bp) at all time points of RA induction. However, they have varied interaction strength with the cis-regulating sequences (-3000 and -8500 bp) during differentiation. In particular, their interactions are generally increased at the EB2 stage. p54nrb, however, has a different interacting pattern, in which the interaction with the -3000-bp region is more constant than the interaction with the -8500-bp region (Figure 6B). The alteration of interaction level during RA-induced differentiation is correlated with the early stage of EB formation. Although the details of the interacting pattern during differentiation may be complex, our data suggest that there are interactions among promoter/enhancer complexes and splicing factors including p54nrb. These data further support that alternative splicing regulation may require the cis-regulating sequence and the basal promoter of the CoAA gene.
###end p 44
###begin title 45
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
The cis-regulating sequence is responsible for alternative splicing switch from CoAA to CoAM during P19 cell differentiation
###end title 45
###begin p 46
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 193 196 193 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 346 354 346 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 764 772 764 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 1292 1300 1292 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 1501 1510 1501 1510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figures 5</xref>
###xml 1516 1517 1516 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7</xref>
###xml 2068 2071 2068 2071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1041 1044 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1118 1121 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
To examine the upstream cis-regulating sequence in regulating alternative splicing of CoAA and CoAM during P19 cell differentiation, we compared the CoAA minigene with different lengths of the cis-regulating sequence. During RA-induced EB formation, the endogenous CoAA gene undergoes a dramatic switch in alternative splicing from CoAA to CoAM (Figure 7). The P0 (-5000 to +88) minigene, though at a reduced expression level, undergoes a similar switch, which has similar timing to that of the endogenous CoAA gene at stage EB4. In contrast, the P2 (-1320 to +88) and the P4 (-410 to +88) minigenes containing the basal promoter region have relatively high levels of expression of both CoAA and CoAM but are unable to induce a complete switch after RA induction (Figure 7). There was up-regulation of CoAM, but the down-regulation of CoAA was totally absent. Thus, when compared to the endogenous gene or P0 minigene, the expression of CoAM transcript from the P2 and P4 minigene fails to remain dominant at the EB4 stage. In addition, the CMV-driven minigene, in which the CoAA basal promoter was substituted with a CMV promoter, shows an incomplete switch in expression between CoAA and CoAM upon RA induction. Quantification of the PCR products in the gel is shown in the lower panels of Figure 7. The transcriptional level appears to be linked with alternative splicing on the CoAA minigene. The higher transcriptional rates in the P2 or P4 minigene are correlated with inadequate CoAM splicing (Figures 5E and 7), whereas a lower transcriptional rate in the P0 minigene shows an almost complete switch from CoAA transcript to CoAM transcript. These data imply a linked transcription rate and alternative splicing regulation, and again suggests that regulatory sequence and promoter context are involved in regulating alternative splicing decisions. As switched expression of CoAA and CoAM is correlated with EB cavitation during stem cell differentiation, the CoAA gene at this stage might be regulated at the alternative splicing level through its promoter and cis-regulating sequence. 
###end p 46
###begin title 47
DISCUSSION
###end title 47
###begin p 48
###xml 548 551 548 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 760 768 760 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 870 873 870 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1034 1037 1034 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1111 1114 1111 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1290 1292 1290 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1083 1088 <span type="species:ncbi:9606">human</span>
Increasing evidence indicates that alternative splicing plays an important role in differentiation and development. We show here, during neuronal stem cell differentiation, the alternative splicing of CoAA switches to its dominant negative CoAM during the cavitation of the EB. To our knowledge, this study is the first to describe the switched expression of alternative splicing variants with antagonizing functions during EB cavitation. The switch subsequently induces the expression of differentiation marker Sox6. In addition, we show that the cis-regulating element of the CoAA gene is required for the switch, which leads to suppressed CoAA activity through both reduced CoAA expression and functional inhibition by CoAM. As shown in the proposed model (Figure 8), while the basal promoter region activates transcription and stimulates the production of CoAA, the cis-regulating sequence represses transcription and stimulates alternative splicing of CoAM. This balance is shifted, presumably by regulating factors, binding the cis-regulating sequence during EB cavitation. In human cancers, in which the cis-regulating sequence was lost from the amplified CoAA gene, this balance might be irreversibly altered so that CoAA is overexpressed, consistent with our previous observation (21); and CoAM may be underexpressed in stem cells with disturbed normal differentiation. Sustained coactivator CoAA expression would be predicted to impact target genes with respect to both transcription and alternative splicing, perhaps contributing to maintaining an undifferentiated cell phenotype. 
###end p 48
###begin p 49
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 1062 1070 1062 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1592 1594 1592 1594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 131 136 <span type="species:ncbi:9606">human</span>
###xml 1416 1421 <span type="species:ncbi:10090">mouse</span>
###xml 1606 1611 <span type="species:ncbi:10090">mouse</span>
The mRNA expression pattern of the endogenous CoAA gene is complex. All three isoforms are identified by RT-PCR in the majority of human tissues and are confirmed by subsequent nucleotide sequencing. Their relative ratio and abundance in each tissue partially reflect the alternative splicing regulation of the CoAA gene. Because of the absence of additional upstream open reading frame in the CoAA gene, the ratio change is less likely due to the nonsense-mediated decay of mRNA (44). Our analysis of protein levels is limited by the overlapping nature of the primary sequences, and the generally low levels of CoAM and CoAR. The endogenous CoAM protein is difficult to detect except in EB. CoAA, however, is found in all cell lines analyzed, including P19 cells, and is abundant in many tissues analyzed with immunohistochemistry. Although CoAR is a functional repressor for CoAA, CoAR may not contribute significantly to the suppressed CoAA activity in the EB cavity, largely because the low levels of expression and the absence of up-regulation at EB stage (Figure 2A). This is probably because both CoAA and CoAR share splicing junctions at exon 1 and exon 3. In contrast, CoAM utilizes a unique splicing junction at exon 2, whose regulation may be separated from that of CoAA. Thus, the observed protein increase in EB cavity is contributed by CoAM. In addition, CoAA protein is expressed in most cells at the mouse E12.5 stage (Supplementary Figure S1). At later stages of development, the expression appears to become gradually restricted to cells undergoing further differentiation (21). In adult mouse, CoAA expression is also quite abundant in some tissues examined, including in germ cells of testis (Supplementary Figure S2). The CoAA expression pattern suggests a functional role of CoAA in multiple tissues. Its dominant negatives, whose levels in specific cells remain to be determined, may regulate CoAA by changing their relative ratios through alternative splicing.
###end p 49
###begin p 50
###xml 133 136 133 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 212 215 212 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 855 858 851 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 959 962 955 958 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 1025 1033 1021 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1127 1130 1123 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 1290 1293 1286 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 1299 1302 1295 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1347 1355 1343 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1426 1429 1422 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1556 1559 1552 1555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1619 1622 1615 1618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 1736 1741 1732 1737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45 B46 B47">45&#8211;47</xref>
###xml 1781 1783 1777 1779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">48</xref>
###xml 1819 1822 1815 1818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 1937 1939 1933 1935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">49</xref>
###xml 1980 1983 1976 1979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 2091 2093 2087 2089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">50</xref>
###xml 2094 2096 2090 2092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 2137 2140 2133 2136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 2211 2214 2207 2210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 73 78 <span type="species:ncbi:9606">human</span>
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
###xml 90 93 <span type="species:ncbi:10116">rat</span>
###xml 227 232 <span type="species:ncbi:9606">human</span>
###xml 251 256 <span type="species:ncbi:10090">mouse</span>
###xml 568 571 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 678 681 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1011 1014 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 2076 2081 <span type="species:ncbi:9606">human</span>
The basal promoter of the CoAA gene appears to be highly conserved among human, mouse and rat species (Supplementary Figure S5). The cis-regulating sequence is also quite conserved with a similar high density of Alu repeats in human and B1 repeats in mouse. These sequence features suggest that the CoAA gene may share a similar regulation cross species. Although protein factors associated with the CoAA regulatory sequences are largely unknown, there are three conserved NF-Y sites and one conserved Sp1 site located within the CoAA basal promoter. In contrast, the CMV promoter contains four cyclic AMP-responsive elements (CREs), three NF-kappaB sites and one Sp1 site. The CMV promoter does not show apparent homology with the CoAA promoter. However, their distinct but overlapping protein-binding profiles might provide the explanation that both p54nrb and PSF induce CoAM expression through the protein interactions on the CoAA promoter, while only p54nrb but not PSF induces CoAM expression through the CMV promoter (Figure 6A). Presumably, the protein complexes on each promoter have differential interactions with p54nrb and PSF. Our ChIP analysis indeed suggests that there are dynamic protein interactions between transcription/splicing complexes and CoAA promoter sequence, or Alu-rich cis-regulating sequence during differentiation (Figure 6). Especially, the protein complexes increase the interaction with the cis-regulating sequence at early stage of EB formation (EB2). Thus, it is evident that the CoAA gene may be regulated through its cis-regulating sequences during EB formation. The functions of Alu repeats have been shown to be associated with gene regulation including CpG methylation-mediated gene silencing (45-47), and hormone-induced gene activation (48). Evidence has also suggested that Alu repeats contain alternative splicing enhancers and silencers, and participate in alternative splicing regulation (49). In addition, the repetitive nature of Alu repeats may facilitate DNA rearrangement, which explains the aberration of the CoAA gene in human cancers (50,21). Although the precise size of the CoAA cis-regulating element has not been defined, our results suggest that the Alu-rich region critically regulates CoAA expression and alternative splicing, at least during stem cell differentiation.
###end p 50
###begin p 51
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">51</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">52</xref>
###xml 545 547 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">53</xref>
Since both the RRMs and the C-terminal activation domain are required for CoAA activity (16), the alternatively spliced CoAM may compete with CoAA through their shared RRMs. The RRM domains have been shown to be the most abundant protein domains in nuclear proteins (51,52), however, several available crystal structure analyses indicate the structures of RRMs are highly specific. For example, the RRMs of hnRNP A1, U1A and sex lethal have their unique peptide architectures with specific interacting surfaces toward nucleic acids or proteins (53). In this regard, the RRM-containing CoAM may compete only with CoAA for the same binding partners and thus serve as a CoAA dominant negative. The abundance of CoAM will then become critical for controlling endogenous CoAA function. And therefore, the switched alternative splicing between CoAA and CoAM may be an important approach to fine-tune CoAA activity, especially during differentiation at the EB stage.
###end p 51
###begin p 52
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">54</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">55</xref>
###xml 561 571 561 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sex-lethal</italic>
###xml 573 576 573 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sxl</italic>
###xml 607 617 607 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 619 622 619 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sxl</italic>
###xml 633 644 633 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">transformer</italic>
###xml 670 680 670 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">double-sex</italic>
###xml 716 717 716 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 724 727 724 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sxl</italic>
###xml 913 916 913 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sxl</italic>
###xml 991 993 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">56</xref>
###xml 1187 1189 1187 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1372 1380 1372 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1486 1488 1486 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">37</xref>
###xml 1775 1778 1775 1778 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 607 617 <span type="species:ncbi:7227">Drosophila</span>
Cell fate determination in stem cell differentiation involves a complex pattern of gene regulation including alternative splicing (54,55). Although RA is a nuclear receptor ligand, its target genes during differentiation are largely undetermined. CoAA as a nuclear receptor coactivator may also regulate an array of genes, including their alternative splicing. A cascade of alternative splicing regulation during differentiation and development has been documented, which might facilitate the understanding of the CoAA function. One of the best examples is the sex-lethal (Sxl) gene in sex determination in Drosophila. Sxl regulates transformer, which in turn regulates double-sex, all through alternative splicing (6). The Sxl transcript is alternatively spliced producing an RRM-containing protein that stimulates its own splicing via a positive feedback mechanism. This establishes and maintains the status of Sxl alternative splicing and determines phenotype of male or female in cells (56). Similarly, the CoAA gene is also alternatively spliced producing splicing regulators with antagonized functions. In addition, CoAA regulates its own gene through positive feedback mechanism (21). In the absence of RA induction, overexpression of CoAM alone, which shares identical RRMs with CoAA, can significantly stimulate the production of the differentiation marker Sox6 (Figure 4). Interestingly, Sox6 and some Sox family members have also been shown to regulate alternative splicing (37). Thus, a potential cascade of splicing regulation involving CoAA might exist during stem cell differentiation. Further studies are needed to confirm if the on/off switch of CoAA controls specific differentiation programs in the mammalian system and which factors, including PSF and p54nrb, are responsible for the switch.
###end p 52
###begin p 53
###xml 195 198 195 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
In summary, we find that the alternative splicing of CoAA switches to its dominant negative form CoAM during EB cavitation of EC cell differentiation. In addition, we show that CoAA promoter and cis-regulating sequences play an important role in regulating alternative splicing. The finding not only provides a potential explanation for oncogenic CoAA in regulating stem cell differentiation, but also supports the concept that the promoter/enhancer participates in alternative splicing decisions.
###end p 53
###begin title 54
SUPPLEMENTARY DATA
###end title 54
###begin p 55
Supplementary Data is available at NAR Online.
###end p 55
###begin title 56
Supplementary Material
###end title 56
###begin title 57
[Supplementary Material]
###end title 57
###begin title 58
ACKNOWLEDGEMENTS
###end title 58
###begin p 59
###xml 110 113 110 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
We thank William S. Dynan and Robert K. Yu for valuable discussions. We thank Yoshihiko Takeda for PSF and p54nrb plasmids. We thank Kimberly K. Smith and Doris B. Cawley for immunohistochemistry analysis. Supported by Georgia Cancer Coalition Distinguished Cancer Scholar Award (L.K.). Funding to pay the Open Access publication charge was provided by Georgia Cancer Coalition.
###end p 59
###begin p 60
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 60
###begin title 61
REFERENCES
###end title 61
###begin article-title 62
Pre-mRNA splicing: life at the centre of the central dogma
###end article-title 62
###begin article-title 63
Function of alternative splicing
###end article-title 63
###begin article-title 64
A genomic view of alternative splicing
###end article-title 64
###begin article-title 65
Structural and functional diversity generated by alternative mRNA splicing
###end article-title 65
###begin article-title 66
The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing
###end article-title 66
###begin article-title 67
Alternative splicing in the control of gene expression
###end article-title 67
###begin article-title 68
###xml 28 33 <span type="species:ncbi:9606">human</span>
Alternative splicing of the human cyclin D-binding Myb-like protein (hDMP1) yields a truncated protein isoform that alters macrophage differentiation patterns
###end article-title 68
###begin article-title 69
Another step forward for SELEXive splicing
###end article-title 69
###begin article-title 70
Alterations of pre-mRNA splicing in cancer
###end article-title 70
###begin article-title 71
Understanding alternative splicing: towards a cellular code
###end article-title 71
###begin article-title 72
A subset of nuclear receptor coregulators act as coupling proteins during synthesis and maturation of RNA transcripts
###end article-title 72
###begin article-title 73
CoAA, a nuclear receptor coactivator protein at the interface of transcriptional coactivation and RNA splicing
###end article-title 73
###begin article-title 74
Promoter usage and alternative splicing
###end article-title 74
###begin article-title 75
Multiple links between transcription and splicing
###end article-title 75
###begin article-title 76
Integrating mRNA processing with transcription
###end article-title 76
###begin article-title 77
Identification and characterization of RRM-containing coactivator activator (CoAA) as TRBP-interacting protein, and its splice variant as a coactivator modulator (CoAM)
###end article-title 77
###begin article-title 78
Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator
###end article-title 78
###begin article-title 79
Coordinate regulation of transcription and splicing by steroid receptor coregulators
###end article-title 79
###begin article-title 80
Paraspeckles: a novel nuclear domain
###end article-title 80
###begin article-title 81
###xml 35 40 <span type="species:ncbi:9606">human</span>
Directed proteomic analysis of the human nucleolus
###end article-title 81
###begin article-title 82
###xml 77 82 <span type="species:ncbi:9606">human</span>
Gene amplification and associated loss of 5' regulatory sequences of CoAA in human cancers
###end article-title 82
###begin article-title 83
Further characterization of embryonic stem cell-derived radial glial cells
###end article-title 83
###begin article-title 84
Twenty one years of P19 cells: what an embryonal carcinoma cell line taught us about cardiomyocyte differentiation
###end article-title 84
###begin article-title 85
Tra2betal regulates P19 neuronal differentiation and the splicing of FGF-2R and GluR-B minigenes
###end article-title 85
###begin article-title 86
Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells
###end article-title 86
###begin article-title 87
Hedgehog signaling induces cardiomyogenesis in P19 cells
###end article-title 87
###begin article-title 88
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
BMP signaling plays a role in visceral endoderm differentiation and cavitation in the early mouse embryo
###end article-title 88
###begin article-title 89
###xml 65 71 <span type="species:ncbi:10090">murine</span>
SRF regulates Bcl-2 expression and promotes cell survival during murine embryonic development
###end article-title 89
###begin article-title 90
Nanog: a new recruit to the embryonic stem cell orchestra
###end article-title 90
###begin article-title 91
The end of the beginning for pluripotent stem cells
###end article-title 91
###begin article-title 92
New type of POU domain in germ line-specific protein Oct-4
###end article-title 92
###begin article-title 93
Sox6 overexpression causes cellular aggregation and the neuronal differentiation of P19 embryonic carcinoma cells in the absence of retinoic acid
###end article-title 93
###begin article-title 94
From head to toes: the multiple facets of Sox proteins
###end article-title 94
###begin article-title 95
Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators
###end article-title 95
###begin article-title 96
A novel splicing regulator shares a nuclear import pathway with SR proteins
###end article-title 96
###begin article-title 97
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
###xml 73 78 <span type="species:ncbi:9606">human</span>
Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families
###end article-title 97
###begin article-title 98
A direct role of SRY and SOX proteins in pre-mRNA splicing
###end article-title 98
###begin article-title 99
###xml 97 104 97 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Role for PSF in mediating transcriptional activator-dependent stimulation of pre-mRNA processing in vivo
###end article-title 99
###begin article-title 100
p54nrb is a component of the snRNP-free U1A (SF-A) complex that promotes pre-mRNA cleavage during polyadenylation
###end article-title 100
###begin article-title 101
Regulation of RNA-polymerase-II-dependent transcription by N-WASP and its nuclear-binding partners
###end article-title 101
###begin article-title 102
PSF and p54(nrb)/NonO-multi-functional nuclear proteins
###end article-title 102
###begin article-title 103
Splicing and transcription-associated proteins PSF and p54nrb/nonO bind to the RNA polymerase II CTD
###end article-title 103
###begin article-title 104
p54(nrb) associates with the 5' splice site within large transcription/splicing complexes
###end article-title 104
###begin article-title 105
A perfect message: RNA surveillance and nonsense-mediated decay
###end article-title 105
###begin article-title 106
###xml 16 21 <span type="species:ncbi:9606">human</span>
Alu repeats and human genomic diversity
###end article-title 106
###begin article-title 107
###xml 81 96 <span type="species:ncbi:10090">transgenic mice</span>
Alu sequence involvement in transcriptional insulation of the keratin 18 gene in transgenic mice
###end article-title 107
###begin article-title 108
DNA methylation and chromatin structure: the puzzling CpG islands
###end article-title 108
###begin article-title 109
###xml 59 64 <span type="species:ncbi:9606">human</span>
Association of some potential hormone response elements in human genes with the Alu family repeats
###end article-title 109
###begin article-title 110
Identification of splicing silencers and enhancers in sense Alus: a role for pseudoacceptors in splice site repression
###end article-title 110
###begin article-title 111
###xml 16 21 <span type="species:ncbi:9606">human</span>
Alu repeats and human disease
###end article-title 111
###begin article-title 112
hnRNP complexes: composition, structure, and function
###end article-title 112
###begin article-title 113
The RNP domain: a sequence-specific RNA-binding domain involved in processing and transport of RNA
###end article-title 113
###begin article-title 114
The RNA recognition motif, a plastic RNA-binding platform to regulate post-transcriptional gene expression
###end article-title 114
###begin article-title 115
Diversification of stem cell molecular repertoire by alternative splicing
###end article-title 115
###begin article-title 116
Alternative splicing increases complexity of stem cell transcriptome
###end article-title 116
###begin article-title 117
###xml 52 62 <span type="species:ncbi:7227">Drosophila</span>
RNA binding protein sex-lethal (Sxl) and control of Drosophila sex determination and dosage compensation
###end article-title 117
###begin title 118
Figures and Tables
###end title 118
###begin p 119
###xml 40 41 40 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 283 284 283 284 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 425 426 425 426 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 339 344 <span type="species:ncbi:9606">human</span>
###xml 515 519 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Alternative splicing of the CoAA gene. (A) Schematic representation of the CoAA gene structure. Introns are shown as lines and the three exons as numbered boxes with alternative splicing events depicted. The spliced mRNAs and their respective protein structures are shown at right. (B) RT-PCR analysis of endogenous CoAA, CoAM and CoAR in human adult and fetal tissues as well as cancer cell lines using GAPDH as a control. (C) Transcriptional activities of CoAA splicing variants were analyzed in CV-1 cells using MMTV-luciferase reporter system, in the presence or absence of dexamethasone (Dex). CoAA activates, and CoAM and CoAR repress the transcriptional activity.
###end p 119
###begin p 120
###xml 100 101 100 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 523 524 523 524 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 587 588 587 588 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 674 675 674 675 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 677 682 <span type="species:ncbi:10090">Mouse</span>
Alternative splicing switch from CoAA to CoAM during P19 embryonal carcinoma cell differentiation. (A) Undifferentiated P19 cells (EC) were induced with 500 nM retinoic acid (RA) in suspension culture up to 4 days to form embryoid bodies (EB2-EB4) which were trypsinized and further differentiated in the tissue culture dish for an additional 12 days in the absence of RA (D3-D12). Total RNA was isolated and normalized at each stage and analyzed using gene-specific primers as indicated by RT-PCR. GAPDH was the control. (B) CoAA and CoAM were analyzed by RT-PCR using shared primers. (C) The relative quantity of CoAA and CoAM was analyzed by quantitative real-time PCR. (D) Mouse ES cells were induced with 1 muM RA for 6 days. The EB was undisrupted in continuous culture for 15 days in the absence of RA. RT-PCR was carried out using RNA isolated at each stage.
###end p 120
###begin p 121
###xml 80 81 80 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 209 210 209 210 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 287 288 287 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 644 645 644 645 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 743 744 743 744 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
###xml 779 784 <span type="species:ncbi:10090">mouse</span>
Expression of CoAA in embryoid body of P19 cells and in brain of mouse embryo. (A) Evaluation of anti-RRM and anti-CoAA antibodies using western blot analysis by overexpression of CoAA and CoAM in 293 cells. (B) Light microscopy of P19 cells at indicated differentiation stages (x400). (C) Embryoid body at Day 4 was paraffin-embedded, sectioned and stained with anti-RRM (against both CoAA and CoAM), anti-CoAA (against CoAA only) and anti-active caspase-3 (against cleaved caspase-3) antibodies. Two representative views are shown (x400). Enlarged views are shown below. The results show CoAM and active caspase-3 staining in the EB cavity. (D) Western blot analysis of CoAA, CoAM and CoAR at indicated differentiation stages of P19 cells. (E) Immunohistochemistry analyses of mouse embryonic brain at gestation stages of E12.5 and E15.5. The sagittal sections were stained with affinity-purified anti-CoAA antibody (1:200) and counterstained with hematoxylin (x400).
###end p 121
###begin p 122
Overexpression of CoAM and treatment with CoAA siRNA induce Sox6 expression in the absence of retinoic acid. P19 cells were transfected with CoAM or with CoAA-specific siRNA (25 nM) at the EC stage, and then were cultured in suspension for 4 days in the absence of RA induction. The cells were trypsinized, plated and further cultured for 3 days. The untreated and RA-induced (for 4 days) P19 cells were similarly cultured as controls. RT-PCR analyses were carried out with indicated marker genes at each indicated stage.
###end p 122
###begin p 123
###xml 32 33 32 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 559 560 559 560 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 777 778 777 778 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 909 910 909 910 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1016 1019 1016 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 1029 1032 1029 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 1045 1048 1045 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 1064 1067 1064 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 1282 1283 1282 1283 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 501 504 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 562 565 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Construction of CoAA minigene. (A) Diagrams show structure of the native CoAA gene and minigene constructions (not to scale). Three CoAA exons are shown as numbered boxes with their alternative splicing events indicated. In the CoAA minigene, the first intron, the second exon (2b) coding the activation domain and 3' untranslated region within the third exon were shortened. A frame-shift mutation was introduced into the first exon to prevent production of RRM domains. The minigene was linked to a CMV promoter or to its natural 5' sequences (not shown). (B) CMV-minigene was transfected and its CoAA and CoAM equivalent transcripts were analyzed by RT-PCR using overexpression of their cDNAs as controls. Vector-specific and isoform-specific primers are indicated in (A). (C) The CoAA minigene shows the absence of transcriptional activity in a luciferase reporter assay using CoAA and CoAM as controls. (D) Diagram illustrates the CoAA first exon and its upstream regulatory sequences. Orientated arrows depict Alu repeats, Alu-Y in black; Alu-S in gray; and Alu-J in white. Enlarged basal promoter region shows predicted Sp1 and NF-Y binding sites as black or white squares, respectively (Supplementary Figure S5). Numbers indicate the length of promoter fragments analyzed. (E) The CoAA promoter fragments, indicated in (D), were linked to luciferase reporter and analyzed by transient transfection assays in P19 cells.
###end p 123
###begin p 124
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 101 102 101 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 228 231 228 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 341 342 341 342 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 442 445 442 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 513 516 513 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 645 646 645 646 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 708 711 708 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 802 805 802 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrb</sup>
###xml 181 184 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
PSF and p54nrb regulate alternative splicing of the CoAA gene through the cis-regulating sequences. (A) Undifferentiated P19 cells were transfected with CoAA P0- or P2-minigene, or CMV minigene together with splicing factors p54nrb or PSF. The expression of CoAA and CoAM equivalent transcripts was analyzed by RT-PCR. GAPDH was a control. (B) Chromatin immunoprecipitation (ChIP) analysis of CoAA basal promoter region (-80 bp) and upstream cis-regulating sequences (-3000 and -8500 bp) using anti-NF-Y, anti-p54nrb anti-RNAP II and anti-SRp20 during P19 cell differentiation. Input was 1%. The resin in the absence of antibody was a control. (C) The figure depicts the interactions (dashed arrows) between cis-regulating sequences and potential splicing and promoter complexes containing RNAP II, p54nrb, SRp20 and NF-Y. Paired arrows indicate the primer locations.
###end p 124
###begin p 125
###xml 76 79 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 210 213 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Switched alternative splicing of CoAA and CoAM is regulated by the upstream cis-regulating sequence. P19 cells were induced by 500 nM retinoic acid for 4 days. The cells were transfected with P0-, P2-, P4-, or CMV-minigene at each stage and the minigene transcripts were analyzed by RT-PCR using isoform-specific primers. GAPDH served as a control. Endogenous CoAA and CoAM transcripts from native CoAA gene were controls. Quantification of PCR products in gel are shown below.
###end p 125
###begin p 126
###xml 510 513 510 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 666 669 666 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
Tentative model of CoAA alternative splicing regulation in the embryoid body of stem cells. CoAA is produced by alternative splicing with inclusion of the second exon. A competitive 5' alternative splicing event excluding a portion of the second exon (2b) produces a dominant negative variant, CoAM, which lacks the activation domain. The basal promoter of the CoAA gene, shown as an open box, promotes splicing of the CoAA form, which is expressed in the outer layer of the embryoid body (gray). The upstream cis-regulating sequence, shown as a filled box, promotes alternative splicing of CoAM, which is expressed in the cavity of EB (white). The loss of upstream cis-regulating element in cancer may prevent the alternative splicing switch and disrupt stem cell differentiation.
###end p 126

